Definium Therapeutics
DFTX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Definium Therapeutics(DFTX) predict that the EBIT is -59.22 M (-84.15%), Miss estimate;the EPS is -0.968 (-100.8%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.06B84.15%
-0.05B51.10%
-0.01B33.05%
EPSMiss expectations
-0.9684100.77%
-0.49542.71%
-0.473098.06%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf